Until now, myeloma patients whose cancer was resistant to commonly used treatment methods and drugs had nowhere to turn. But a Phase 2 CAR T-cell...
Day: 15 January 2019
CAR T Cell Therapy Market to Reflect Impressive Growth Rate
Increasing incidence of cancer and rising number of patients showing response failure to alternative treatments is expected to foster growth of the...